← SynDRA
DEFOSBARASERTIB
SynDRA canonical compound SYN0006391 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
| Primary target(s) | AURKB |
| Mechanism of action | Aurora kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- aurora kinase inhibitor
- AURKB INHIBITOR
- AURKB MODULATOR
Cross-references
Synonyms
- AZD-2811
- AZD-1152 HQPA
- Azd2811
- Barasertib-hqpa
- AZD-1152HQPA
- INH-34
- AZD-1152-HQPA
- Barasertib
- barasertib-hqpa
- AZD1152
- AZD 1152
- Barasertib [INN]
- Barasertib (who-dd)
- 2-(ETHYL(3-((4-((5-(2-((3-FLUOROPHENYL)AMINO)-2-OXOETHYL)-1H-PYRAZOL-3-YL)AMINO)QUINAZOLIN-7-YL)OXY)PROPYL)AMINO)ETHYL DIHYDROGEN PHOSPHATE
- 16XC2U7W8N
- CHEMBL415049
- BARASERTIB [WHO-DD]
- 2-(ethyl(3-(4-(5-(2-(3-fluorophenylamino)-2-oxoethyl)-1H-pyrazol-3-ylamino)quinazolin-7-yloxy)propyl)amino)ethyl dihydrogen phosphate
- 5-[[7-[3-[Ethyl[2-(phosphonooxy)ethyl]amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-1H-pyrazole-3-acetamide
- 2-(Ethyl(3-((4-((3-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-5-yl)amino)quinazolin-7-yl)oxy)propyl)amino)ethyl dihydrogen phosphate
- 2-[ethyl-[3-[4-[[5-[2-(3-fluoroanilino)-2-oxoethyl]-1H-pyrazol-3-yl]amino]quinazolin-7-yl]oxypropyl]amino]ethyl dihydrogen phosphate
- AZD1152 (Barasertib)
- barasertibum
- UNII-16XC2U7W8N
- 2-{ethyl[3-({4-[(5-(2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl]amino}ethyl dihydrogen phosphate
- Kinome_3324
- 2-NAPHTHYLACRYLATE
- SCHEMBL613582
- GTPL7332
- SCHEMBL16671950
- DTXSID00222583
- CHEBI:167636
- BCPP000362
- HMS3674C21
- HMS3747E05
- BCP01734
- BCP13793
- CS-D0326
- EX-A3656
Look up DEFOSBARASERTIB in the interactive SynDRA portal →